Planta Med 2022; 88(08): 685-692
DOI: 10.1055/a-1540-4978
Biological and Pharmacological Activity
Original Papers

Benzoylcyclopropane Derivatives from Hypoxis hemerocallidea Corms

Autoren

  • Fazila Zulfiqar

    1   National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA
  • Pankaj Pandey

    1   National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA
  • Siddharth K. Tripathi

    1   National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA
  • Zulfiqar Ali

    1   National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA
  • Amar G. Chittiboyina

    1   National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA
  • Ikhlas A. Khan

    1   National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA
    2   Division of Pharmacognosy, Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS, USA

Gefördert durch: U.S. Department of Agriculture 58-6060-6-015

Abstract

Two monobenzoylcyclopropane (hypoxhemerol A (1) and hypoxhemeroloside G (2)) and three dibenzoylcyclopropane (hypoxhemerol B (3), hypoxhemeroloside H (4), and hypoxhemeroloside I (5)) derivatives were isolated from the hydro-alcoholic extract of Hypoxis hemerocallidea corms. This is the first instance where benzoylcyclopropane analogs were isolated from any natural source. Structure elucidation was mainly based on 1D- and 2D-NMR and HRESIMS data. The absolute configuration (2R, 4R) of 1 was determined via NOESY NMR and experimental and calculated ECD data analyses. Compounds 15 and 11 recently reported metabolites (hypoxoside, obtuside A, interjectin, acuminoside, curcapicycloside, and hypoxhemerolosides A – F) were screened for in vitro antimicrobial activity against various bacterial and fungal strains. Curcapicycloside and acuminoside exhibited antibacterial activity against Escherichia coli with 78 and 79% inhibition at 20 µg/mL, respectively. Hypoxhemeroloside A showed mild antifungal activity against Cryptococcus neoformans with 63% inhibition at 20 µg/mL.

Supporting Information



Publikationsverlauf

Eingereicht: 10. Februar 2021

Angenommen nach Revision: 25. Juni 2021

Artikel online veröffentlicht:
30. Juli 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany